Ifinatamab Deruxtecan Continues to Demonstrate Promising Objective Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial

Tomas Kauer - Moderator

Sep 8, 2024 - 02:00

Ifinatamab Deruxtecan Continues to Demonstrate Promising Objective Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial

Tags:

Previous Article

Autopsy suggests tycoon Mike Lynch likely died of suffocation in yacht - source

Typhoon Yagi hits north Vietnam killing two and closing airports

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator

Related Posts

EU's top court rules against Apple, Google in two major decisions

EU's top court rules against Apple, Google in two major...

Tomas Kauer - Mode... Sep 10, 2024

Frenchman accused of mass rapes of drugged wife too ill to testify this week

Frenchman accused of mass rapes of drugged wife too ill...

Tomas Kauer - Mode... Sep 12, 2024

James Earl Jones, renowned actor and voice of Darth Vader, dies at 93

James Earl Jones, renowned actor and voice of Darth Vad...

Tomas Kauer - Mode... Sep 10, 2024